Gastroparesis Drugs Market: $6,662.35 Million by 2032, 4.4% CAGR

The gastroparesis drugs market size was valued at USD 4,529.75 million in 2023. The market is anticipated to grow from USD 4,720.90 million in 2024 to USD 6,662.35 million by 2032, exhibiting a CAGR of 4.4% between 2024 and 2032.

Market Overview:
Gastroparesis is a disorder in which the stomach gets paralyzed. This paralysis interferes with the normal working of the stomach, resulting in food getting stuck in the stomach. Individuals suffering from gastroparesis have trouble consuming food as there is a decrease in appetite. This results in leaving behind a hard mass of food in the stomach, causing discomfort to the patient. Gastroparesis drugs aim to solve this disorder by stimulating movement in the stomach in order to pass the undigested food from the stomach.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/gastroparesis-drugs-market/request-for-sample

Major Participants:
Numerous pharmaceutical companies are continuously innovating, researching, and finding new ways to improve the efficacy of gastroparesis drugs. Some of the major companies in the gastroparesis market are:
• Abbott Laboratories (US)
• AbbVie Inc. (US)
• Allergan Inc. (US)
• Evoke Pharma (US)
• Medtronic Plc (Ireland)
• Neurogastrx Inc. (US)
• Pfizer Inc. (US)
• Rhythm Pharmaceuticals Inc. (US)
• Salix Pharmaceuticals (US)
• TEVA Pharmaceutical (Israel)
• Vanda Pharmaceuticals Inc. (US)

Growth Drivers:
• The increasing prevalence of gastroparesis among diabetic patients is boosting the market growth. As the incidents pertaining to diabetes are increasing dramatically worldwide, the risk of developing gastroparesis among individuals also rises. Also, the surging aging or geriatric population, who are more susceptible to the disease due to several physical changes in the body, are prone to relying on the gastroparesis drug market.

• The rising number of regulatory approvals for new and improved drugs for the treatment of gastroparesis from major government authorities such as the US Food and Drug Administration and European Medicines Association, coupled with the expansion of existing treatment solutions, is projected to have a positive impact on global market growth.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/gastroparesis-drugs-market/request-for-discount-pricing

Segmental Analysis

• The gastroparesis market is segmented based on drug class, disease class, end user, and region.

• The drug class segment is categorized into prokinetic agents, antiemetic agents, and botulinum toxin injections. The prokinetic agents segment accounted for the largest share in 2023.

• The end user segment is categorized into hospitals, pharmacies, clinics, and e-commerce. The pharmacies segment is expected to witness the fastest growth during the forecast period.

Regional Overview:
Gastroparesis Drugs Market, Regional Outlook (Revenue - USD Million, 2019-2032)
o North America
 Drug Class Outlook
 Prokinetic Agents
 Antiemetic Agents
 Botulinum Toxin Injections
 Disease Class Outlook
 Diabetic Gastroparesis
 Idiopathic Gastroparesis
 Post-surgical Gastroparesis
 Others
 End User Outlook
 Hospitals
 Pharmacies
 Clinics
 E-commerce

o Europe
 Drug Class Outlook
 Prokinetic Agents
 Antiemetic Agents
 Botulinum Toxin Injections
 Disease Class Outlook
 Diabetic Gastroparesis
 Idiopathic Gastroparesis
 Post-surgical Gastroparesis
 Others
 End User Outlook
 Hospitals
 Pharmacies
 Clinics
 E-commerce

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/gastroparesis-drugs-market

📌More Trending Latest Reports by Polaris Market Research:
U.S. Pet Insurance Market:
https://www.polarismarketresearch.com/industry-analysis/us-pet-insurance-market

Rotator Cuff Repair Market:
https://www.polarismarketresearch.com/industry-analysis/rotator-cuff-repair-market

Corneal Pachymetry Market:
https://www.polarismarketresearch.com/industry-analysis/corneal-pachymetry-market

AI In Medical Imaging Market:
https://www.polarismarketresearch.com/industry-analysis/ai-in-medical-imaging-market

Trachoma Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/trachoma-treatment-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.